AU2002251633A1 - Novel use of proton pump inhibitors - Google Patents

Novel use of proton pump inhibitors

Info

Publication number
AU2002251633A1
AU2002251633A1 AU2002251633A AU2002251633A AU2002251633A1 AU 2002251633 A1 AU2002251633 A1 AU 2002251633A1 AU 2002251633 A AU2002251633 A AU 2002251633A AU 2002251633 A AU2002251633 A AU 2002251633A AU 2002251633 A1 AU2002251633 A1 AU 2002251633A1
Authority
AU
Australia
Prior art keywords
proton pump
pump inhibitors
novel use
novel
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002251633A
Inventor
Lars Engstrand
Martin Holmberg
Rolf Larsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Forskarpatent I Uppsala AB
Original Assignee
Forskarpatent I Uppsala AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forskarpatent I Uppsala AB filed Critical Forskarpatent I Uppsala AB
Publication of AU2002251633A1 publication Critical patent/AU2002251633A1/en
Abandoned legal-status Critical Current

Links

AU2002251633A 2001-04-06 2002-04-05 Novel use of proton pump inhibitors Abandoned AU2002251633A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101231-9 2001-04-06
SE0101229-3 2001-04-06

Publications (1)

Publication Number Publication Date
AU2002251633A1 true AU2002251633A1 (en) 2002-10-21

Family

ID=

Similar Documents

Publication Publication Date Title
AU2001296908A1 (en) Proton pump inhibitor formulation
AU2002351179A1 (en) Glycinamides as factor xa inhibitors
AU2003241464A1 (en) Compositions and methods using proton pump inhibitors
AU2003282891A1 (en) Novel tyrosine kinases inhibitors
AU2002339348A1 (en) Inhibition of STAT-1
AU2002366796A1 (en) Methods using proton pump inhibitors
AU2002363838A1 (en) Pump
AU2002238103A1 (en) Use of beta-lactamase inhibitors as neuroprotectants
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2002240942A1 (en) Improved delivery of benefit agents
AU2002356615A1 (en) Novel utilization of cyclopentabenzofurans
AU2002222933A1 (en) Inhibitors of factor xa
AU2002316552A1 (en) Inhibitor of t cell activation
AU2002342682A1 (en) Protease inhibitors
AU2002322551A1 (en) Antisense modulation of rip2 expression
AU2002253350A1 (en) 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors
AU2002305868A1 (en) Inhibitors of reggamma
AU2002251633A1 (en) Novel use of proton pump inhibitors
AU2002346812A1 (en) Use of 1-phenyl-oxazolidine-2-one compounds as protease m inhibitors
AU2002221882A1 (en) Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors
AU2002258749A1 (en) Inhibitors of glycosaminoglycans
AU2003238034A1 (en) Novel use of imidazotriazinones
AU2002328906A1 (en) Inhibitors of polyq-aggregation
SE0101231D0 (en) Novel use of proton pump inhibitors
AU2002241204A1 (en) 3-heterocyclylpropanohydroxamic acid pcp inhibitors